This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universitá Degli Studi Di Siena. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Giorgio Giorgi
Introduction
Giorgio Giorgi is a notable inventor based in Siena, Italy. He has made significant contributions to the field of immunology and oncology through his innovative research and patents. His work focuses on developing therapeutic solutions that can combat tumors effectively.
Latest Patents
Giorgi holds a patent for a poly-epitope peptide derived from thymidylate synthase, which exhibits immunological and anti-tumor activity. This invention is particularly important as it concerns a peptide that not only has anti-tumor preventive and therapeutic activity but can also be used in combination with other established anti-tumor compounds, such as 5-fluorouracil. This patent highlights his commitment to advancing cancer treatment options.
Career Highlights
Giorgi is affiliated with the Università Degli Studi Di Siena, where he conducts his research and contributes to the academic community. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to improving patient outcomes through scientific innovation.
Collaborations
Giorgi collaborates with esteemed colleagues, including Pierpaolo Correale and Maria Grazia Cusi. These partnerships enhance the research environment and foster the development of groundbreaking solutions in the field of medicine.
Conclusion
Giorgio Giorgi's contributions to the field of immunology and oncology through his innovative patent demonstrate his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future research and development in cancer therapies.